Print

Drug Improves Cognitive Function in Mouse Model of Down Syndrome, Stanford University School of Medicine Study  
7/3/2013 7:26:32 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

An existing FDA-approved drug improves cognitive function in a mouse model of Down syndrome, according to a new study by researchers at the Stanford University School of Medicine. The drug, an asthma medication called formoterol, strengthened nerve connections in the hippocampus, a brain center used for spatial navigation, paying attention and forming new memories, the study said. It also improved contextual learning, in which the brain integrates spatial and sensory information.

Hey, check out all the research scientist jobs. Post your resume today!

//-->